This meta-analysis also revealed an increase in Tregs' frequency, FOXP3 expression, and IL-10 expression in vitiligo after microRNA-based treatment, narrow band–UVB phototherapy, and Treg-associated treatments, indicating that targeting Treg cells in vitiligo patients could lead to effective therapeutics. This evidence concerns the gene FOXP3 and vitiligo.